Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-07-03
2007-07-03
Le, Long V. (Department: 1641)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C435S326000, C435S331000, C435S007100
Reexamination Certificate
active
11060831
ABSTRACT:
Disclosed are antibodies to phosphorylated tau, methods of making and methods of use.
REFERENCES:
patent: 5492812 (1996-02-01), Vooheis
patent: 5601985 (1997-02-01), Trojanowski et al.
patent: 5843779 (1998-12-01), Vandermeeren et al.
patent: 5861257 (1999-01-01), Vandermeeren et al.
patent: 6008024 (1999-12-01), Vandermeeren et al.
patent: 6010913 (2000-01-01), Vandermeeren et al.
patent: 6121003 (2000-09-01), Vanmechelen et al.
patent: 6232437 (2001-05-01), Vandermeeren et al.
patent: 6238892 (2001-05-01), Mercken et al.
patent: 6376205 (2002-04-01), Wischik et al.
patent: 6417185 (2002-07-01), Goff et al.
patent: 6500674 (2002-12-01), Vandermeeren et al.
patent: 6512096 (2003-01-01), Weiner et al.
patent: 6589746 (2003-07-01), Zemlan
patent: 6664443 (2003-12-01), Hutton et al.
patent: 2002/0001857 (2002-01-01), Vandermeeren et al.
patent: 2002/0019016 (2002-02-01), Vanmechelen et al.
patent: 2002/0168687 (2002-11-01), Wischik et al.
patent: 2002/0188106 (2002-12-01), Mandelkow et al.
patent: 2003/0113896 (2003-06-01), Zinkowski et al.
patent: 2003/0133874 (2003-07-01), Roder
patent: 2003/0138972 (2003-07-01), Vandermeeren et al.
patent: 2003/0143760 (2003-07-01), Vandermeeren et al.
patent: 2003/0165575 (2003-09-01), Iqbal et al.
patent: 2003/0194742 (2003-10-01), Vanmechelen et al.
Sharma et al. “Spatial Localization of Tyrosine Phosphorylated Tau”, Society for Neuroscience Abstract Viewer and Itinerary Planner, (2002) vol. 2002, pp. Abstract No. 592.19, http://sfn.scholarone.com, Meeting Info.: 32nd Annual Meeting of the Society for Neuroscience. Orlando, Flordia, USA, Nov. 2-7, 2002, Society for Neuroscience.
Lee et al. “Tyrosine Phosphorylated Tau is in Neurofibrillary Tangles” Program No. 19.10. 2003 Society for Neuroscience Abstract Viewer/Itinerary Planner. Online: https://sfn.scholarone.com. Meeting Info.: 33rd Annual Meeting of the Society for Neuroscience. New Orleans, LA, USA, Nov. 8-12, 2003.
Harlow & Lane. “Antibodies: A Laboratory Manual” (1988) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 27-34, 141-142, 421, and 423-428.
Arendt, T., “Alzheimer's Disease as a Loss of Differentiation Control in a Subset of Neurons that Retain Immature Features in the Adult Brain,”Neurobiology of Aging(2000) 21:783-796.
Bamberger, M.E. et al., “A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation,”J. Neuroscience(2003) 23:7:2665-2674.
Bondareff, W. et al., “Immunohistochemical Staging of Neurofibrillary Degeneration in Alzheimer's Disease,”J. Neuropath. Exp. Neurol.(1994) 53:2:158-164.
Bramblett, G.T. et al., “Abnormal Tau Phosphorylation at Ser396In Alzheimer's Disease Recapitulates Development and Contributes to Reduces Microtubule Binding,”Neuron(1993) 10:1089-1099.
Brandt, R. and Lee, G., “Functional Organization Of Microtubule-Associated Protein Tau.”J. Biol. Chem.(1993) 268:5:3414-3419.
Carmel et al., “The Structural Basis of Monoclonal Antibody Alz50's Selectivity for Alzheimer's Disease Pathology,”J. Biol. Chem.(1996) 271:51:32789-32795.
Davis, H.L. et al., “Cpg DNA is a Potent Enhancer of Specific Immunity in Mice Immunized with Recombinant Hepatitis B Surface Antigen,”J. Immunol.(1998) 160:2:870-876.
Dente, L. et al., “Modified Phage Peptide Libraries as a Tool to Study Specificity of Phosphorylation and Recognition of Tyrosine Containing Peptides,”J. Mol. Biol.(1997) 269:694-703.
Dickson, D.W. et al., “Immunocytochemistry of Neurofibrillary Tangles with Antibodies to Subregions of Tau Protein: Identification of Hidden and Cleaved Tau Epitopes and a New Phosphorylation Site,”Acta Neuropath.(1992) 84:596-605.
Digiovanna, M.P., et al., Production of Antibodies that Recognize Specific Tyrosine-Phosphorylated Peptides (2003).Current Protocols in Immunology, (1996) 11.6.1-11.6.19.
Endoh, R. et al., “Lack of theCarboxyl Terminal Sequence of Tau in Ghost Tangles of Alzheimer's Disease,”Brain Res.(1993) 601:164-172.
Garcia-Sierra, F. et al., “Conformational Changes and Truncation of Tau Protein During Tangle Evolution in Alzheimer's Disease,”J. Alzheimers Dis.(2003) 5:65-77.
Ghoshal, N. et al., “Tau Conformational Changes Correspond to Impairments of Episodic Memory in Mild Cognitive Impairment and Alzheimer's Disease,”Exp. Neurol.(2002) 177:475-493.
Goedert, M. et al., “The Abnormal Phosphorylation of Tau Protein at Ser-202 in Alzheimer Disease Recapitulates Phosphorylation During Development,”Proc. Natl. Acad. Sci. USA(1993) 90:5066-5070.
Grace, E.A. and Busciglio, J., “Aberrant Activation of Focal Adhesion Proteins Mediates Fibrillar Amyloid Beta-Induced Neuronal Dystrophy,”J. Neurosci.(2003) 23:2:493-502.
Grant, S.G. et al., “Impaired Long-Term Potentiation, Spatial Learning, and Hippocampal Development infynMutant Mice,”Science(1992) 258:1903-1910.
Hall, G.F. et al., “Human Tau Becomes Phosphorylated and Forms Filamentous Deposits with Overexpressed in Lamprey Central Neurons In Situ,”Proc. Natl. Acad. Sci. USA(1997) 94:4733-4738.
Herrup, K. and Yang, Y., “Pictures in Molecular Medicine: Contemplating Alzheimer's Disease as Cancer:a Loss of Cell-Cycle Control,”Trends Mol. Med.(2001) 7:11:527.
Jicha, G.A. et al., “A Conformation- and Phosphorylation-Dependent Antibody Recognizing the Paired Helical Filaments of Alzheimer's Disease,”J. Neurochem.(1997) 69:5:2087-2095.
Johnson et al., “The τ Protein in Human Cerebrospinal Fluid in Alzheimer's Disease Consists of Proteolytically Derived Fragments,”J. Neurochem.(1997) 68:1:430-433.
Kanemaru, K. et al., “Fetal-Type Phosphorylation of the τ in Paired Helical Filaments,”J. Neurochem.(1992) 58:5:1667-1675.
Kim, H. et al., “Evidence for Tau Expression of Cells in Monocyte Lineage and its in Vitro Phosphorylation by V-Fms Kinase,”Oncogene(1991) 6:1085-1087.
Klein, C. et al., “Process Outgrowth of Oligodendrocytes is Promoted by Interaction of fyn Kinase with the Cytoskeletal Protein Tau,”J. Neurosci.(2002) 22:3:698-707.
Ksiezak-Reading, H. and Wall, J.S., “Mass and Physical Dimensions of Two Distinct Populations of Paired Helical Filaments,”Neurobiol. Aging(1994) 15:1:11-19.
Lambert, M.P. et al., “Diffusible, Nonfibrillar Ligands Derived From Abeta 1-42 are Potent Central Nervous System Neurotoxins,”Proc. Natl. Acad. Sci. USA(1998) 95:6448-6453.
Lee, G., “The Microtubule Binding Domain of Tau Protein,”Neuron(1989) 2:1615-1624.
Lee, G., “Tau Interacts with Src-Family Non-Receptor Tyrosine Kinases,”J. Cell Sci.(1998) 111:3167-3177.
Lee, G. et al., “Phosphorylation of tau by Fyn: Implications for Alzheimer's disease,” J. Neurosci. (2004) 24(9):2304-2312.
Lee, G. and Rook, S.L., “Expression of Tau Protein in Non-Neuronal Cells: Microtubule Binding and Stabilization,”J. Cell Sci.(1992) 102:227-237.
Lowell, C.A. and Soriano, P., “Knockouts of Src-Family Kinases: Stiff Bones, Wimpy T Cells and Bad Memories,”Genes Dev.(1996) 10:1845-1857.
Lu, K.P. et al., “Proline-Directed Phosphorylation and Isomerization in Mitotic Regulation and in Alzheimer's Disease,”Bioessays.(2003) 25:174-181.
Luo, Y. et al., “Physiologic Levels of β-Amyloid Activate Phosphatidylinositol 3-Kinase with the Involvement of Tyrosine Phosphorylation,”J. Neurochem.(1996) 67:3:978-987.
Luo, Y.Q. et al., “Physiological Levels of β-Amyloid Increase Tyrosine Phosphorylation and Cytosolic Calcium,”Brain Res.(1995) 681:65-74.
Mandell, J.W. and Banker, G.A., “A Spatial Gradient of Tau Protein Phosphorylation in Nascent Axons,”J. Neurosci.(1996) 16:18:5727-5740.
Maness, P.F., “Nonreceptor Protein Tyrosine Kinases Associated with Neuronal Development,”Dev. Neurosci.(1992) 14:257-270.
Foster Christine
Le Long V.
Michael & Best & Friedrich LLP
University of Iowa Foundation
LandOfFree
Antibodies to phosphorylated tau, methods of making and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to phosphorylated tau, methods of making and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to phosphorylated tau, methods of making and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3771404